Stocktoria
Traws Pharma, Inc. ONTX
CBOE · stock · Pharmaceutical Preparations · website · IPO 2013-07-25
Traws Pharma, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8M | $226,000 | $226,000 | $226,000 | $226,000 | $231,000 | $2.2M | $1.2M | $787,000 | $5.5M |
| R&D expense | — | — | $11.4M | $11.4M | $7.3M | $16.9M | $15.5M | $16.9M | $19.1M | $20.1M |
| Operating income | -$17.9M | -$142.4M | -$20.3M | -$19.6M | -$16.5M | -$25.0M | -$21.7M | -$23.3M | -$25.7M | -$23.7M |
| Income tax | — | — | — | — | — | $4,000 | $10,000 | -$124,000 | $13,000 | $14,000 |
| Net income | $9.2M | -$166.5M | -$18.9M | -$19.0M | -$16.2M | -$25.2M | -$21.5M | -$20.6M | -$24.1M | -$19.7M |
| EPS (diluted) | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | — | — | — | — |
| Operating cash flow | -$18.2M | -$29.8M | -$17.9M | -$16.3M | -$19.5M | -$23.1M | -$20.8M | -$22.7M | -$23.8M | -$15.8M |
| Free cash flow | — | — | -$17.9M | — | — | -$23.1M | -$20.9M | — | — | — |
| Cash & equivalents | — | — | $20.6M | $38.5M | — | — | — | — | — | $21.4M |
| Total assets | $10.6M | $25.0M | $22.7M | $39.4M | $55.5M | $20.0M | $23.7M | $17.9M | $5.0M | $23.2M |
| Total liabilities | $11.2M | $56.6M | $12.0M | $11.1M | $9.4M | $13.8M | $12.1M | $12.5M | $15.8M | $18.1M |
| Shareholders' equity | -$629,000 | -$31.6M | $10.7M | $28.3M | $46.1M | $6.2M | $11.6M | $5.4M | -$11.7M | $5.1M |
Growth · year-over-year · Revenue CAGR -7.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1134.5% | +0.0% | +0.0% | +0.0% | -2.2% | -89.4% | +77.8% | +56.0% | -85.8% | -51.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.